HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
HTL Biotechnology’s first symposium at the congress was a resounding success. With a focus on collagen, DNA, and regenerative medicine, we had the opportunity to showcase our cutting-edge technologies, which participants found particularly innovative.
The connections established during the congress promise a bright future for these solutions and reflect growing interest in our expertise.
This first edition confirmed the importance of HTL Biotechnology’s presence at such a prominent event, paving the way for future collaborations and developments.
The European Society of Cataract and Refractive Surgeons (ESCRS) is a unique opportunity each year to connect with our clients and partners while gaining insights into the key trends shaping the future of ophthalmology.
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.